作者
Gülhan Turan-Zitouni, Ahmet Özdemir, Zafer Asim Kaplancikli, Kadriye Benkli, Pierre Chevallet, Gulsen Akalin
发表日期
2008/5/1
期刊
European journal of medicinal chemistry
卷号
43
期号
5
页码范围
981-985
出版商
Elsevier Masson
简介
The increasing clinical importance of drug-resistant mycobacterial pathogens has lent additional urgency to microbiological research and new antimycobacterial compound development. For this purpose, new thiazolylhydrazone derivatives were synthesized and evaluated for antituberculosis activity. The reaction of thiosemicarbazide with acetophenone derivatives gave 1-(1-arylethylidene)thiosemicarbazide (1). The N-(1-arylethylidene)-N′-[4-(indan-5-yl)thiazol-2-yl]hydrazone (3) derivatives were synthesized by reacting 1-(1-arylethylidene)thiosemicarbazide with 1-(5-indanyl)-2-bromoethanone (2). The chemical structure of the compounds was elucidated by elemental analyses, IR, 1H NMR, MS-FAB+ spectral data. Antituberculosis activities of the synthesized compounds were determined by broth microdilution assay, the Microplate Alamar Blue Assay, in BACTEC12B medium and the results were screened in …
引用总数
2009201020112012201320142015201620172018201920202021202220233546311895136751
学术搜索中的文章
G Turan-Zitouni, A Özdemir, ZA Kaplancikli, K Benkli… - European journal of medicinal chemistry, 2008